The Chinese University of Hong Kong
Overview
The Chinese University of Hong Kong is a public research university that operates as an institutional investor, primarily through its endowment and its wholly-owned subsidiary, CUHK Innovation Limited, which provides early-stage funding to university spin-offs and startups.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Ynno Med | Apr 2024 | Grant | Co-investor |
| Ynno Med | Apr 2023 | Grant | Co-investor |
| Ynno Med | Apr 2022 | Grant | Co-investor |
| Medmind Technology | Mar 2022 | Grant | Co-investor |
| GenieBiome Limited | Aug 2020 | Series A | Co-investor |
Key People
ananya roy
Reading Group Founder of Green Worlds Nature, Narrative, and More-than-Human Pasts and Futures, Teaching Assistant, Research Assistant
Billy Yu
Founder and President of the CUHK Alumni Association of Environmental Science
Christopher H.K. Cheng
Professor at the School of Biomedical Sciences and Managing Director of HKIB
Joaquim Vong
Deputy Managing Director of Core Labs, School of Biomedical Sciences, Scientific Officer, School of Biomedical Sciences
John A. Rudd
Managing Director, Animal Holding Core, School of Biomedical Sciences, Professor
Louisa Tsang
Managing Director, Clinical Research Management Office and Phase 1 Clinical Trial Centre
三石 Enders
Managing Director
Clara Lau
Associate Director of Institute of Chinese Medicine, Associate Director of Partner State Key Lab of Phytochemistry & Plant Resources in West China (CUHK)
John Lai
Principal Lecturer, Director, Office of Co-operative Education Programme (OCEP), Assistant Dean (Undergraduate Studies) and Director, Integrated BBA Dual Degree Programme
Siu-lun Lee
首席講師 Principal Lecturer, 首席講師 Principal Lecturer
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
